Clinical Trial News and Research

RSS

Misdiagnosed Parkinson's patient regains life after NPH treatment

At age 66, Richard "Dick" Nash first suspected something might be wrong when he participated in a Dallas walk for juvenile diabetes in honor of his granddaughter.

26 Feb 2026

Combining stem cell therapy with fetal surgery shows promise for treating myelomeningocele

A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida.

26 Feb 2026

Novel lipid bubble delivery shows promise for ALS treatment

A researcher at the University of Missouri has made a promising breakthrough in the quest to help people with amyotrophic lateral sclerosis (ALS), the neurodegenerative disorder commonly known as Lou Gehrig's disease.

26 Feb 2026

Fifteen-year follow up reveals cure potential in follicular lymphoma

Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard regimens of immunotherapy and a chemotherapy combination known as CHOP suggests that many of those patients can now be considered cured.

26 Feb 2026

Innovative laser procedure offers new hope for recurrent brain tumors

High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients

26 Feb 2026

New daily tablet simplifies long-term HIV care

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according to the results of a new phase 3 clinical trial published in The Lancet.

26 Feb 2026

New single pill regimen simplifies treatment for resistant HIV

A phase 3 clinical trial, led by Professor Chloe Orkin of Queen Mary University of London, has shown that a new, daily oral tablet that combines two current HIV treatment medications – bictegravir and lenacapavir (BIC/LEN) – may simplify treatment significantly for people with HIV who currently take very complex treatments.

25 Feb 2026

Meningococcal B vaccine fails to prevent gonorrhea, trial shows

Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhea, according to the results of the world's largest randomized control trial (RCT) into possible efficacy, conducted by Griffith University's Institute for Biomedicine and Glycomics and the Kirby Institute at UNSW Sydney.

25 Feb 2026

SolasCure completes Phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, CLEANVLU2. The study demonstrated that its investigational product, Aurase Wound Gel (AWG), heals chronic wounds at a faster rate than current standard of care, providing clinical validation of its ability to deliver continuous enzymatic debridement while simultaneously activating wound healing.

24 Feb 2026

Barshop Institute at UT Health San Antonio secures major federal funding for longevity trial

Positioning The University of Texas at San Antonio as a national anchor for aging and longevity science, its Sam and Ann Barshop Institute for Longevity and Aging Studies will receive up to $38 million in federal funding for the first nationwide clinical study in healthy longevity.

24 Feb 2026

New global guidelines improve reporting of pediatric randomized controlled trials

Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family caregivers, have developed a child- and youth-centred global standard for reporting paediatric randomized controlled trials (RCTs) protocols and final reports.

24 Feb 2026

Daily peanut butter intake boosts muscle power in older adults

A clinical trial by researchers at Deakin University's Institute for Physical Activity and Nutrition (IPAN) in Melbourne, Australia, found that a daily serving of peanut butter significantly boosted muscle power in older adults.

24 Feb 2026

Centauri Therapeutics extends Series A to £30 M with £6 M investment from AMR Action Fund to support progression of lead clinical candidate

Centauri Therapeutics Limited ('Centauri'), an immunotherapy company with a unique and proprietary platform technology applicable across a wide range of therapeutic indications, today announced it has secured £6 M from AMR Action Fund, extending the Company's Series A round to £30 M.

24 Feb 2026

Early exposure to unhealthy foods leaves lasting brain and feeding changes

Eating unhealthy foods early in life leave lasting brain and feeding changes but gut bacteria can help restore healthy eating, new University College Cork (UCC) research study finds today (Tuesday 24th February 10am)

24 Feb 2026

Five sessions a day TMS approach may reduce depression symptoms in one week

For the many patients with depression who haven't found relief through medication, transcranial magnetic stimulation (TMS) - a noninvasive therapy that uses magnetic pulses to stimulate specific areas of the brain - has become an increasingly important treatment option.

23 Feb 2026

Milken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for sarcoidosis

The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future clinical trial in cutaneous sarcoidosis.

20 Feb 2026

Screening helps detect colorectal cancer at an early stage

More cases of colorectal cancer are detected at an early stage with screening. This is according to new research based on data from over 278,000 60-year-olds, who were randomly selected to undergo one of two interventions or no screening at all (usual care).

20 Feb 2026

Stereotactic radiation improves quality of life in patients with brain metastases

In a Phase 3 randomized trial, Mass General Brigham researchers found that stereotactic radiation targeting individual tumors led to lower symptom burden, better cognitive outcomes, and better day to day function when compared with whole brain radiation

19 Feb 2026

Precision mRNA vaccine strategy shows early promise for improving TNBC relapse risk

An individualized neoantigen mRNA vaccine was tested in patients with early-stage triple-negative breast cancer and showed feasibility, safety, and strong T cell immune responses. Long-term follow-up suggested durable immune memory with encouraging relapse-free outcomes, though controlled trials are needed to confirm clinical benefit.

19 Feb 2026

Onset of "the munchies" after cannabis use could offer clues to help people with appetite loss

The urgent onset of "the munchies" after cannabis use isn't imaginary – it's a cognitive response that occurs regardless of sex, age, weight or recent food consumption and could offer clues to help people struggling with appetite loss.

19 Feb 2026

Previous
1
...
27
28
29
30
31
32
33
...
1183
Next

Clinical Trial News and Research

Misdiagnosed Parkinson's patient regains life after NPH treatment

Combining stem cell therapy with fetal surgery shows promise for treating myelomeningocele

Novel lipid bubble delivery shows promise for ALS treatment

Fifteen-year follow up reveals cure potential in follicular lymphoma

Innovative laser procedure offers new hope for recurrent brain tumors

New daily tablet simplifies long-term HIV care

New single pill regimen simplifies treatment for resistant HIV

Meningococcal B vaccine fails to prevent gonorrhea, trial shows

SolasCure completes Phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel

Barshop Institute at UT Health San Antonio secures major federal funding for longevity trial

New global guidelines improve reporting of pediatric randomized controlled trials

Daily peanut butter intake boosts muscle power in older adults

Centauri Therapeutics extends Series A to £30 M with £6 M investment from AMR Action Fund to support progression of lead clinical candidate

Early exposure to unhealthy foods leaves lasting brain and feeding changes

Five sessions a day TMS approach may reduce depression symptoms in one week

Milken Institute and Ann Theodore Foundation fund mTOR inhibitor trial for sarcoidosis

Screening helps detect colorectal cancer at an early stage

Stereotactic radiation improves quality of life in patients with brain metastases

Precision mRNA vaccine strategy shows early promise for improving TNBC relapse risk

Onset of "the munchies" after cannabis use could offer clues to help people with appetite loss

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Metabolomics

Improve fermentation and cell culture performance with real-time gas analysis

Scaling patient-derived organoid research

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer